Shanghai Fosun Pharmaceutical (Group) Co Ltd (SFOSF)
1.695
+0.10
(+6.60%)
USD |
OTCM |
May 17, 16:00
Shanghai Fosun Pharmaceutical Profit Margin (Quarterly): 6.00% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.00% |
| December 31, 2023 | 0.96% |
| September 30, 2023 | 5.43% |
| June 30, 2023 | 7.51% |
| March 31, 2023 | 9.08% |
| December 31, 2022 | 10.50% |
| September 30, 2022 | 8.76% |
| June 30, 2022 | 9.84% |
| March 31, 2022 | 4.40% |
| December 31, 2021 | 9.73% |
| September 30, 2021 | 10.72% |
| June 30, 2021 | 18.38% |
| March 31, 2021 | 10.52% |
| December 31, 2020 | 14.43% |
| September 30, 2020 | 9.47% |
| June 30, 2020 | 13.96% |
| March 31, 2020 | 9.82% |
| December 31, 2019 | 17.10% |
| September 30, 2019 | 7.76% |
| June 30, 2019 | 10.80% |
| March 31, 2019 | 10.58% |
| December 31, 2018 | 9.06% |
| September 30, 2018 | 8.49% |
| June 30, 2018 | 13.92% |
| March 31, 2018 | 12.34% |
| Date | Value |
|---|---|
| December 31, 2017 | 12.65% |
| September 30, 2017 | 15.85% |
| June 30, 2017 | 21.27% |
| March 31, 2017 | 19.01% |
| December 31, 2016 | 15.76% |
| September 30, 2016 | 18.28% |
| June 30, 2016 | 23.34% |
| March 31, 2016 | 19.66% |
| December 31, 2015 | 16.10% |
| September 30, 2015 | 18.64% |
| June 30, 2015 | 24.58% |
| March 31, 2015 | 19.15% |
| December 31, 2014 | 16.00% |
| September 30, 2014 | 17.84% |
| June 30, 2014 | 20.89% |
| March 31, 2014 | 15.64% |
| December 31, 2013 | 21.60% |
| September 30, 2013 | 13.18% |
| June 30, 2013 | 28.59% |
| March 31, 2013 | 17.12% |
| December 31, 2012 | 24.10% |
| September 30, 2012 | 20.67% |
| June 30, 2012 | 19.83% |
| March 31, 2012 | 20.36% |
| December 31, 2011 | 5.29% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
0.96%
Minimum
Dec 2023
18.38%
Maximum
Jun 2021
9.76%
Average
9.77%
Median
Profit Margin (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | -279.5% |
| Zai Lab Ltd | -61.36% |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 3.58% |
| Return on Assets | 1.80% |
| Return on Invested Capital | 2.27% |
| Gross Profit Margin (Quarterly) | 50.01% |
| Operating Margin (Quarterly) | 9.81% |
| Return on Net Operating Assets | 2.93% |